Literature DB >> 17890237

Characterization of Drosophila telomeric retroelement TAHRE: transcription, transpositions, and RNAi-based regulation of expression.

Sergey Shpiz1, Dmitry Kwon, Anastasiya Uneva, Maria Kim, Mikhail Klenov, Yakov Rozovsky, Pavel Georgiev, Mikhail Savitsky, Alla Kalmykova.   

Abstract

Telomeres in Drosophila are maintained by transpositions of specialized telomeric retroelements HeT-A and TART rather than by the telomerase activity adding short DNA repeats to chromosome ends in other eukaryotes. A novel element TAHRE was previously found in the telomeric regions of the genome of Drosophila melanogaster stock sequenced by the Genome Project. Comparative genomic analysis confirmed by Southern analysis and in situ hybridization of polytene chromosomes reveals conserved TAHRE elements in the genomes of melanogaster subgroup species. Spontaneous attachment of TAHRE retroelement to the broken end of terminally deleted chromosome allows us to consider TAHRE as the third retrotransposon family involved in telomere maintenance in Drosophila. The abundance of TAHRE transcripts in ovaries is strongly upregulated owing to mutations in the RNA interference genes spn-E, aub, piwi, and vasa locus. spn-E mutations eliminate TAHRE-specific short RNAs in the ovaries. These data suggest that TAHRE is a conservative element involved along with HeT-A and TART in telomere maintenance and a target of the RNAi-based system in the Drosophila germ line. This study reveals similar distribution of TAHRE and HeT-A transcripts, which accumulate in the oocyte, whereas TART transcripts localize in nurse cells. Taking into account a common pattern of HeT-A and TAHRE expression, one may consider TAHRE as a source of reverse transcriptase enzymatic activity for HeT-A transpositions in ovaries.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890237     DOI: 10.1093/molbev/msm205

Source DB:  PubMed          Journal:  Mol Biol Evol        ISSN: 0737-4038            Impact factor:   16.240


  25 in total

1.  Genetic variation of copia suppression in Drosophila melanogaster.

Authors:  W Vu; S Nuzhdin
Journal:  Heredity (Edinb)       Date:  2010-07-07       Impact factor: 3.821

Review 2.  Co-evolution between transposable elements and their hosts: a major factor in genome size evolution?

Authors:  J Arvid Ågren; Stephen I Wright
Journal:  Chromosome Res       Date:  2011-08       Impact factor: 5.239

3.  Retrotransposons that maintain chromosome ends.

Authors:  Mary-Lou Pardue; P G DeBaryshe
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-05       Impact factor: 11.205

Review 4.  Useful parasites: the evolutionary biology and biotechnology applications of transposable elements.

Authors:  Georgi N Bonchev
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

Review 5.  Retrotransposons at Drosophila telomeres: host domestication of a selfish element for the maintenance of genome integrity.

Authors:  Liang Zhang; Yikang S Rong
Journal:  Biochim Biophys Acta       Date:  2012-02-04

Review 6.  Regulation of telomere length in Drosophila.

Authors:  R Capkova Frydrychova; H Biessmann; J M Mason
Journal:  Cytogenet Genome Res       Date:  2009-01-30       Impact factor: 1.636

Review 7.  Untangling the web: the diverse functions of the PIWI/piRNA pathway.

Authors:  Sneha Ramesh Mani; Celina E Juliano
Journal:  Mol Reprod Dev       Date:  2013-06-27       Impact factor: 2.609

Review 8.  The biogenesis and function of PIWI proteins and piRNAs: progress and prospect.

Authors:  Travis Thomson; Haifan Lin
Journal:  Annu Rev Cell Dev Biol       Date:  2009       Impact factor: 13.827

Review 9.  A 'higher order' of telomere regulation: telomere heterochromatin and telomeric RNAs.

Authors:  Stefan Schoeftner; Maria A Blasco
Journal:  EMBO J       Date:  2009-07-23       Impact factor: 11.598

10.  rasiRNA pathway controls antisense expression of Drosophila telomeric retrotransposons in the nucleus.

Authors:  Sergey Shpiz; Dmitry Kwon; Yakov Rozovsky; Alla Kalmykova
Journal:  Nucleic Acids Res       Date:  2008-11-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.